Algert Global LLC Kura Oncology, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

A detailed history of Algert Global LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Algert Global LLC holds 272,276 shares of KURA stock, worth $2.01 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
272,276
Previous 260,783 4.41%
Holding current value
$2.01 Million
Previous $5.37 Million 0.93%
% of portfolio
0.14%
Previous 0.18%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$18.57 - $23.23 $213,425 - $266,982
11,493 Added 4.41%
272,276 $5.32 Million
Q2 2024

Aug 14, 2024
SELL
$17.53 - $22.98 $329,336 - $431,725
-18,787 Reduced 6.72%
260,783 $5.37 Million
Q1 2024

May 14, 2024
SELL
$13.42 - $23.53 $723,069 - $1.27 Million
-53,880 Reduced 16.16%
279,570 $5.96 Million
Q4 2023

Feb 14, 2024
SELL
$7.58 - $14.38 $239,330 - $454,034
-31,574 Reduced 8.65%
333,450 $4.8 Million
Q3 2023

Nov 13, 2023
BUY
$8.44 - $11.86 $1.5 Million - $2.11 Million
177,959 Added 95.13%
365,024 $3.33 Million
Q2 2023

Aug 14, 2023
BUY
$9.62 - $13.99 $524,386 - $762,594
54,510 Added 41.12%
187,065 $1.98 Million
Q1 2023

May 12, 2023
SELL
$10.71 - $14.6 $314,456 - $428,670
-29,361 Reduced 18.13%
132,555 $1.62 Million
Q4 2022

Feb 13, 2023
SELL
$11.23 - $16.9 $238,076 - $358,279
-21,200 Reduced 11.58%
161,916 $2.01 Million
Q3 2022

Nov 15, 2022
BUY
$12.01 - $19.45 $852,697 - $1.38 Million
70,999 Added 63.33%
183,116 $2.5 Million
Q2 2022

Aug 15, 2022
BUY
$10.71 - $18.33 $221,482 - $379,064
20,680 Added 22.62%
112,117 $2.06 Million
Q1 2022

May 16, 2022
BUY
$11.78 - $16.98 $637,674 - $919,161
54,132 Added 145.11%
91,437 $1.47 Million
Q4 2021

Feb 14, 2022
SELL
$12.22 - $19.57 $88,961 - $142,469
-7,280 Reduced 16.33%
37,305 $522,000
Q3 2021

Nov 15, 2021
BUY
$15.42 - $21.72 $184,777 - $260,270
11,983 Added 36.76%
44,585 $835,000
Q2 2021

Aug 13, 2021
SELL
$20.85 - $29.88 $145,866 - $209,040
-6,996 Reduced 17.67%
32,602 $680,000
Q1 2021

May 14, 2021
SELL
$24.75 - $39.14 $919,462 - $1.45 Million
-37,150 Reduced 48.41%
39,598 $1.12 Million
Q4 2020

Feb 12, 2021
BUY
$29.0 - $41.62 $813,711 - $1.17 Million
28,059 Added 57.63%
76,748 $2.51 Million
Q3 2020

Nov 16, 2020
SELL
$16.3 - $30.64 $405,169 - $761,618
-24,857 Reduced 33.8%
48,689 $1.49 Million
Q2 2020

Aug 12, 2020
SELL
$7.95 - $18.81 $64,959 - $153,696
-8,171 Reduced 10.0%
73,546 $1.2 Million
Q1 2020

May 13, 2020
BUY
$6.45 - $14.04 $340,560 - $741,312
52,800 Added 182.59%
81,717 $813,000
Q4 2019

Feb 18, 2020
BUY
$12.97 - $15.94 $375,053 - $460,936
28,917 New
28,917 $398,000

Others Institutions Holding KURA

# of Institutions
186
Shares Held
81.7M
Call Options Held
42.1K
Put Options Held
34K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $494M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email